Radiant Logistics (RLGT) Reaches $5.24 After 7.00% Up Move; 16 Analysts Bullish Alexion Pharmaceuticals, Inc. (ALXN)

The stock of Radiant Logistics Inc (NYSEMKT:RLGT) is a huge mover today! About 213,837 shares traded. Radiant Logistics Inc (NYSEMKT:RLGT) has risen 71.19% since August 26, 2016 and is uptrending. It has outperformed by 62.44% the S&P500.The move comes after 7 months positive chart setup for the $258.29M company. It was reported on Apr, 4 by Barchart.com. We have $5.61 PT which if reached, will make NYSEMKT:RLGT worth $18.08M more.

Among 22 analysts covering Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), 16 have Buy rating, 0 Sell and 6 Hold. Therefore 73% are positive. Alexion Pharmaceuticals Inc. had 47 analyst reports since July 27, 2015 according to SRatingsIntel. The company was maintained on Tuesday, June 7 by Morgan Stanley. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Outperform” rating by RBC Capital Markets on Thursday, December 22. The stock of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) earned “Buy” rating by Stifel Nicolaus on Friday, December 11. The firm has “Neutral” rating by Wedbush given on Friday, September 23. The firm has “Perform” rating given on Thursday, December 15 by Oppenheimer. The stock has “Buy” rating by Stifel Nicolaus on Friday, July 29. The firm has “Neutral” rating given on Thursday, February 25 by Citigroup. The stock has “Buy” rating by Goldman Sachs on Friday, October 28. Brean Capital maintained it with “Buy” rating and $221 target in Friday, July 31 report. Barclays Capital maintained Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) on Thursday, February 4 with “Equal-Weight” rating. See Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) latest ratings:

30/03/2017 Broker: UBS Rating: Buy Initiates Coverage On
02/03/2017 Broker: Nomura Rating: Buy Initiates Coverage On
17/02/2017 Broker: RBC Capital Markets Rating: Outperform Old Target: $187 New Target: $177 Maintain
22/12/2016 Broker: RBC Capital Markets Rating: Outperform Old Target: $188 New Target: $187 Maintain
15/12/2016 Broker: Oppenheimer Rating: Perform Initiate
13/12/2016 Broker: Morgan Stanley Old Rating: Overweight New Rating: Equal-Weight Downgrade
29/11/2016 Broker: Barclays Capital Old Rating: Equal-Weight New Rating: Overweight Upgrade
03/11/2016 Broker: Deutsche Bank Rating: Buy New Target: $164.00 Initiate
28/10/2016 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Upgrade
28/10/2016 Broker: Wedbush Rating: Neutral Old Target: $132.00 New Target: $135.00 Maintain

Radiant Logistics, Inc. operates as a third-party logistics company, providing multi-modal transportation and logistics services. The company has market cap of $258.29 million. The Firm is organized in two geographic operating divisions: United States and Canada. It has a 491.56 P/E ratio. The Company’s transportation services for both the United States and Canada divisions are placed into categories of freight forwarding and freight brokerage services.

Since March 8, 2017, it had 0 insider buys, and 1 sale for $36,165 activity. $36,165 worth of Radiant Logistics Inc (NYSEMKT:RLGT) was sold by BENTO E JOSEPH.

Analysts await Radiant Logistics Inc (NYSEMKT:RLGT) to report earnings on May, 15. They expect $0.01 EPS, down 75.00% or $0.03 from last year’s $0.04 per share. RLGT’s profit will be $492,920 for 131.00 P/E if the $0.01 EPS becomes a reality. After $0.10 actual EPS reported by Radiant Logistics Inc for the previous quarter, Wall Street now forecasts -90.00% negative EPS growth.

Investors sentiment increased to 2.05 in 2016 Q4. Its up 0.76, from 1.29 in 2016Q3. It improved, as 6 investors sold Radiant Logistics Inc shares while 13 reduced holdings. 16 funds opened positions while 23 raised stakes. 15.43 million shares or 1.67% more from 15.18 million shares in 2016Q3 were reported. Walleye Trading Ltd Llc invested in 0% or 3,600 shares. Bnp Paribas Arbitrage holds 0% of its portfolio in Radiant Logistics Inc (NYSEMKT:RLGT) for 2,199 shares. Legal And General Gru Public Ltd stated it has 6,526 shares. Cadence Cap Management Lc invested 0.06% of its portfolio in Radiant Logistics Inc (NYSEMKT:RLGT). Thompson Davis & Incorporated reported 34,750 shares stake. Bb&T Securities Limited Liability Corporation reported 0% in Radiant Logistics Inc (NYSEMKT:RLGT). The Germany-based Deutsche State Bank Ag has invested 0% in Radiant Logistics Inc (NYSEMKT:RLGT). Blackrock Fund Advsrs stated it has 1.21M shares. State Street Corporation has invested 0% in Radiant Logistics Inc (NYSEMKT:RLGT). Nationwide Fund has invested 0% of its portfolio in Radiant Logistics Inc (NYSEMKT:RLGT). Schwab Charles Investment Mgmt Inc invested 0% in Radiant Logistics Inc (NYSEMKT:RLGT). Wellington Management Ltd Liability Partnership stated it has 0% in Radiant Logistics Inc (NYSEMKT:RLGT). Moreover, Blackrock has 0% invested in Radiant Logistics Inc (NYSEMKT:RLGT). State Common Retirement Fund has 0% invested in Radiant Logistics Inc (NYSEMKT:RLGT). Dimensional Fund Advsrs Limited Partnership owns 675,118 shares.

Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $26.63 billion. The Firm is focused on the development and commercialization of therapeutic products. It has a 67.37 P/E ratio. The Company’s products include Soliris , Strensiq (asfotase alfa) and Kanuma (sebelipase alfa).

Since October 14, 2016, it had 0 buys, and 31 selling transactions for $20.62 million activity. On Friday, October 14 Thiel Carsten sold $551,364 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 4,584 shares. 3,978 Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) shares with value of $524,922 were sold by BELL LEONARD. Moriarty John B sold $123,829 worth of stock or 1,044 shares. On Thursday, March 2 O’Neill Julie sold $87,104 worth of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) or 651 shares. 1,932 shares valued at $243,371 were sold by Wagner Heidi L on Monday, February 6. 1,045 shares were sold by Miller Edward, worth $131,357 on Monday, February 6. 3,570 shares were sold by Carmichael Clare, worth $449,135 on Monday, February 6.

About 740,071 shares traded. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has declined 7.98% since August 26, 2016 and is downtrending. It has underperformed by 16.73% the S&P500.